<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04614831</url>
  </required_header>
  <id_info>
    <org_study_id>CAIN457A2023</org_study_id>
    <nct_id>NCT04614831</nct_id>
  </id_info>
  <brief_title>A Worldwide Survey on the Understanding of Psoriatic Disease Among Patients With Psoriasis and Psoriatic Arthritis</brief_title>
  <official_title>Psoriasis and Beyond: A Worldwide Survey on the Understanding of Psoriatic Disease Among Patients With Psoriasis and Psoriatic Arthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novartis Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novartis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a Worldwide Survey on the Understanding of Psoriatic Disease among Patients with&#xD;
      Psoriasis and Psoriatic Arthritis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a cross-sectional, quantitative online survey of patients with psoriasis with or&#xD;
      without concomitant psoriatic arthritis. Following assessment of participant eligibility via&#xD;
      a 5-minute online screener, the 25-minute internet-based survey will be conducted without any&#xD;
      follow-up.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 12, 2020</start_date>
  <completion_date type="Actual">June 3, 2021</completion_date>
  <primary_completion_date type="Actual">June 3, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>A web-based survey will be answered by the participants. Data collected for the analysis of the primary objective include validated patient-reported outcomes (such as DLQI), as well as responses to non-validated questions.</measure>
    <time_frame>1 Day of survey</time_frame>
    <description>To assess patients' understanding of psoriasis and psoriatic arthritis as part of a systemic disease and the humanistic and physical burden of living with the condition.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>A web-based survey will be answered by the participants. The data collected for the analysis of the secondary objectives include validated tools (such as PAM-13), as well as responses to non-validated questions.</measure>
    <time_frame>1 Day of Survey</time_frame>
    <description>To assess the patient's perceptions and attitudes related to the relationship with their physician, the patient journey through the healthcare system, as well as barriers to self-management, diagnosis, patient perceptions on biologics, treatment expectations, and satisfaction with care.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">4978</enrollment>
  <condition>Plaque Psoriasis, Psoriatic Arthritis</condition>
  <arm_group>
    <arm_group_label>Psoriasis and Psoriatic Arthritis</arm_group_label>
    <description>The study population consists of adults who self-report to have been diagnosed with psoriasis with or without concomitant psoriatic arthritis</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will consist of adults with self-reported Psoriasis and/or Psoriatic&#xD;
        Arthritis. Screening questions will be used to determine the eligibility for each&#xD;
        respondent to the survey.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients who self-report to have been diagnosed with Psoriasis or Psoriasis and&#xD;
             Psoriatic Arthritis before or at the time of data collection&#xD;
&#xD;
          2. Patients 18 years of age or older at the time of data collection&#xD;
&#xD;
          3. Patients who did not participate in surveys regarding Psoriasis or Psoriatic Arthritis&#xD;
             in the last 4 weeks&#xD;
&#xD;
          4. Body Surface Area (BSA) of &gt;5 to &lt;10, with psoriasis affecting sensitive and/or&#xD;
             prominent body parts: face, palms, hands, fingers, genitals, soles of feet or nails or&#xD;
             a BSA of 10 and above, when psoriasis was at its worst&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Novartis Investigational Site</name>
      <address>
        <city>Basel</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>October 29, 2020</study_first_submitted>
  <study_first_submitted_qc>November 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 4, 2020</study_first_posted>
  <last_update_submitted>July 20, 2021</last_update_submitted>
  <last_update_submitted_qc>July 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Psoriatic</mesh_term>
    <mesh_term>Psoriasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

